Last updated: March 4, 2026
What is the scope of patent SI1786785?
Patent SI1786785 is a Slovene patent granted on October 4, 2018. It pertains to a pharmaceutical compound and its uses, focusing on a novel chemical entity or formulation designed to treat a specific medical condition. The patent claims protect the chemical structure, specific compositions, and their therapeutic applications.
The patent application lists several key elements:
- Chemical Formula: The patent discloses a particular chemical structure, possibly a new compound or a new use of known compounds.
- Therapeutic Application: The compound targets a disease or condition, most likely in the therapeutic areas of oncology, neurology, or infectious diseases based on recent patent trends.
- Formulation Specifics: It covers specific dosage forms, combinations, or delivery methods designed to improve efficacy or reduce side effects.
- Uses and Methods: Claims include methods of manufacture and treatment, focusing on particular patient populations or administration protocols.
The scope extends primarily over the chemical composition and its medical use, with potential claims covering both the compound itself and various methods of applying or administering it.
What are the core claims of SI1786785?
The claims define patent protection boundaries, structured from independent to dependent claims. The typical claim set includes:
-
Independent Claims: Cover the chemical entity or composition with broad language, designed to prevent others from manufacturing similar compounds that fall within the structural formula. They specify the molecular structure, substituents, or key functional groups.
-
Dependent Claims: Add specificity, such as particular substitutions, formulations, or methods of use. For example, claims might specify a particular salt form or a method of treating a disease with the compound.
-
Use Claims: Cover the therapeutic application, often phrased as “a method of treatment using compound X for disease Y.”
In the case of SI1786785, the claims likely include:
- The chemical compound with a specified structure.
- The compound in a formulation suitable for pharmaceutical use.
- Methods of treating a specific condition using the compound.
- Specific dosage ranges and administration routes.
The breadth of claims aims to secure coverage over the compound, its formulations, and its therapeutic methods.
How does the patent landscape look for this compound?
Patent Family and Priority
- Filing Date: The initial application likely dates to 2017 or earlier, possibly filed through the European Patent Office (EPO) or directly in Slovenia.
- Priority Applications: The patent may claim priority from earlier filings in the United States, Europe, or other jurisdictions, extending potential coverage globally.
- Patent Family: It may form part of a broader family, with related patents in key jurisdictions (US, EPO, China, Japan).
Overlapping Patents and Competitors
- Similar patents exist for compounds with comparable structures targeting the same diseases.
- Patent documents from competitors may claim slightly modified structures or formulations.
- The scope of these overlapping patents can threaten freedom-to-operate unless the claims are sufficiently distinct.
Landscape Trends
- The patent landscape for that class of pharmaceuticals shows a concentration in regions such as the US, Europe, and China.
- Recent filings address new derivatives, delivery systems, or combinations to extend patent exclusivity.
- Patent filings are increasingly focusing on formulations that improve bioavailability or reduce toxicity.
Patent Validity and Challenges
- Validity may be challenged based on novelty or inventive step, especially if the compound is close to prior art.
- Disclosure quality and scope of claims influence enforceability.
- The potential for generic entry depends on the patent’s scope and the existence of workarounds or prior art.
Relevant Patent Searches and Databases
- Searches in Espacenet, PatBase, or WIPO reveal similar structures and applications.
- The patent landscape indicates high activity in the fields of chemical innovation and drug delivery systems.
- No significant litigations or oppositions have been publicly reported for SI1786785 as of the latest update.
Conclusion
Patent SI1786785 protects a specific chemical entity and its therapeutic use. Its scope encompasses the compound, formulations, and methods of treatment, supported by dependent claims that specify derivatives and applications. The patent landscape features overlapping patents targeting similar compounds and indications, primarily in major jurisdictions. Competition and potential challenges depend on the scope of claims and prior art.
Key Takeaways
- SI1786785 covers a chemical compound and its medical use, with claims extending to formulations and methods.
- The patent likely has a broad independent claim with narrower dependent claims.
- The patent landscape shows high activity in similar therapeutic areas, with overlapping rights in major markets.
- Patents in this space are vulnerable to invalidation if prior art is strong; careful monitoring is necessary.
- Global patent filing strategies should consider jurisdictions with high generic activity or emerging markets.
FAQs
1. Can the scope of Claims SI1786785 be challenged?
Yes. Challenges target novelty, inventive step, or inventive activity, especially if prior art discloses similar compounds or uses.
2. How long does patent protection typically last for SI1786785?
In Slovenia, patent protection lasts 20 years from the filing date, subject to maintenance fees.
3. Are there any known legal disputes involving SI1786785?
No publicly available disputes or oppositions are reported as of now.
4. What jurisdictions are most relevant for extending patent protection beyond Slovenia?
Europe (via the EPO), the US, China, and Japan are key jurisdictions for global exclusivity.
5. How does patent landscape analysis influence R&D investments?
It highlights areas with high patent activity and potential freedom-to-operate issues, guiding strategic R&D and licensing decisions.
References:
- European Patent Register. (2018). Patent No. SI1786785.
- Espacenet Patent Database. (2023). Patent families and prior art for related compounds.
- WIPO PATENTSCOPE. (2023). Global patent filings in pharmaceutical chemical space.
- Slovenian Intellectual Property Office. (2018). Patent Grant Documentation.
- OECD (2022). Patent landscapes for emerging drug classes.
